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Abstract 
 
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in the United 
States and is greatly exacerbated by metabolic syndrome (MetS). Current techniques to diagnose 
CAD are invasive, expensive, and their appropriateness varies among physicians. Therefore, they 
cannot be used as a routine screening test to predict CAD. To assess the severity of the CAD 
disease, the diagnostic tests determine with various degrees of accuracy the percentage level of 
phenotypes such as atheroma wall coverage, stenosis, and plaque composition in the coronary 
arteries. These phenotypes are measured using invasive methods such as IVUS; in comparison to 
other phenotypes such as the insulin level that do not require such invasive methods, but at the 
same time, these phenotypes are less accurate for diagnosis purposes. In addition to predicting 
the CAD disease, there is a need to improve early screening of the disease without having to use 
invasive methods such as IVUS. The objective of the study described in this poster is to develop 
an accurate and non-invasive informatics approach to facilitate screening and monitoring of 
patients with CAD using a combination of plasma proteomics data and the non-invasively 
generated phenotypes (e.g. insulin level). This study concentrates on using machine-learning 
approach to predict ranges of values (e.g. low, moderate, high percentage) for the invasively 
generated phenotypes, with a special focus on atheroma wall coverage. The ranges of values are 
mapped to different stages in the CAD disease. 
 
 
